KEMSA MCP Contract Exceeds $509M for Medical Commodities, Awarded Sole-Source
Contract Overview
Contract Amount: $509,539,555 ($509.5M)
Contractor: Kenya Medical Supplies Author ITY
Awarding Agency: Agency for International Development
Start Date: 2015-09-25
End Date: 2024-07-09
Contract Duration: 3,210 days
Daily Burn Rate: $158.7K/day
Competition Type: NOT COMPETED
Number of Offers Received: 1
Pricing Type: COST PLUS AWARD FEE
Sector: Healthcare
Official Description: IGF::CL::IGFKEMSA MEDICAL COMMODITIES PROGRAM (KEMSA MCP)
Plain-Language Summary
Agency for International Development obligated $509.5 million to KENYA MEDICAL SUPPLIES AUTHOR ITY for work described as: IGF::CL::IGFKEMSA MEDICAL COMMODITIES PROGRAM (KEMSA MCP) Key points: 1. Significant spending on medical commodities through a sole-source contract. 2. Contract duration is extensive, spanning over 8 years. 3. Lack of competition raises concerns about price discovery and value for money. 4. The sector is critical for public health, making oversight paramount.
Value Assessment
Rating: questionable
The contract's cost-plus award fee structure, combined with a sole-source award, makes direct pricing comparisons difficult. Without competitive bidding, it's challenging to ascertain if the pricing reflects fair market value for the medical commodities procured.
Cost Per Unit: N/A
Competition Analysis
Competition Level: sole-source
The contract was not competed, indicating a sole-source award. This limits price discovery and potentially leads to higher costs for taxpayers as there was no market pressure to achieve the lowest possible price.
Taxpayer Impact: The sole-source nature of this large contract may result in suboptimal pricing, potentially increasing the financial burden on taxpayers for essential medical supplies.
Public Impact
Ensures availability of critical medical commodities for public health programs. Potential for inflated costs due to lack of competition impacts healthcare budget. Long-term nature of the contract may hinder adoption of newer, more cost-effective solutions.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Sole-source award
- Lack of competition
- Cost-plus award fee structure
- Long contract duration
Positive Signals
- Addresses critical need for medical commodities
- Long-term commitment ensures supply chain stability
Sector Analysis
This contract falls within the broader professional, scientific, and technical services sector, specifically related to the procurement and distribution of medical commodities. Spending benchmarks for such specialized services can vary widely, but the scale and sole-source nature here warrant scrutiny.
Small Business Impact
The provided data does not indicate any specific provisions or participation by small businesses in this contract. Further analysis would be needed to determine if small businesses had opportunities to participate or benefit.
Oversight & Accountability
The sole-source award and cost-plus fee structure necessitate robust oversight to ensure funds are used efficiently and effectively. Transparency in performance metrics and cost justifications is crucial for accountability.
Related Government Programs
- All Other Professional, Scientific, and Technical Services
- Agency for International Development Contracting
- Agency for International Development Programs
Risk Flags
- Lack of competition
- Potential for overpricing
- Limited transparency in pricing
- Long contract duration may stifle innovation
- Cost-plus award fee structure can be complex to oversee
Tags
all-other-professional-scientific-and-te, agency-for-international-development, definitive-contract, 100m-plus
Frequently Asked Questions
What is this federal contract paying for?
Agency for International Development awarded $509.5 million to KENYA MEDICAL SUPPLIES AUTHOR ITY. IGF::CL::IGFKEMSA MEDICAL COMMODITIES PROGRAM (KEMSA MCP)
Who is the contractor on this award?
The obligated recipient is KENYA MEDICAL SUPPLIES AUTHOR ITY.
Which agency awarded this contract?
Awarding agency: Agency for International Development (Agency for International Development).
What is the total obligated amount?
The obligated amount is $509.5 million.
What is the period of performance?
Start: 2015-09-25. End: 2024-07-09.
What was the justification for awarding this contract sole-source, and how was the pricing determined to be fair and reasonable?
The justification for a sole-source award typically involves unique capabilities, urgent needs, or lack of viable alternatives. Without this specific justification, it's difficult to assess the fairness of the pricing. A thorough review of the contract file and any pre-award surveys would be necessary to understand the rationale and the process used to establish a fair and reasonable price, especially given the cost-plus award fee structure.
What are the key performance indicators (KPIs) for this contract, and how are they being monitored to ensure value for taxpayer money?
Key performance indicators for a medical commodities contract would likely include delivery timeliness, product quality, stock availability, and adherence to specifications. Monitoring these KPIs is crucial, especially with a cost-plus award fee structure, to ensure the contractor is meeting performance targets and that the award fee is justified. Regular performance reviews and audits by the Agency for International Development are essential for accountability.
How does the cost-plus award fee structure incentivize efficiency and cost savings for the government in this sole-source contract?
A cost-plus award fee (CPAF) structure aims to incentivize contractor performance by allowing reimbursement of allowable costs plus a fee that is composed of a base fee and an award amount. The award amount is typically tied to meeting or exceeding specific performance objectives. However, in a sole-source context, the effectiveness of this incentive in driving down costs is debatable, as the contractor may have less pressure to be highly cost-conscious compared to a competitive environment.
Industry Classification
NAICS: Professional, Scientific, and Technical Services › Other Professional, Scientific, and Technical Services › All Other Professional, Scientific, and Technical Services
Product/Service Code: SUPPORT SVCS (PROF, ADMIN, MGMT) › PROFESSIONAL SERVICES
Competition & Pricing
Extent Competed: NOT COMPETED
Solicitation Procedures: ONLY ONE SOURCE
Offers Received: 1
Pricing Type: COST PLUS AWARD FEE (R)
Evaluated Preference: NONE
Contractor Details
Address: 13 COMMERCIAL STREET, NAIROBI
Business Categories: Category Business, Corporate Entity Tax Exempt, Foreign Owned, Nonprofit Organization, Not Designated a Small Business, Special Designations
Financial Breakdown
Contract Ceiling: $646,439,978
Exercised Options: $646,439,978
Current Obligation: $509,539,555
Actual Outlays: $118,765,184
Contract Characteristics
Multi-Year Contract: Yes
Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED
Cost or Pricing Data: NO
Timeline
Start Date: 2015-09-25
Current End Date: 2024-07-09
Potential End Date: 2024-07-09 00:00:00
Last Modified: 2024-07-09
Other Agency for International Development Contracts
- - Ghsc Idiq - Hiv/Aids to — $6.7B (Chemonics International, Inc.)
- Covid-19 Vaccines for International Donation — $4.2B (Pfizer Inc)
- This IS a NEW Task Order (# 03) Issued Against the Basic IQC # Gpo-I-00-05-00032-00. the Purpose of This Task Order IS to Facilitate Continuation of the Scms Program in ALL Pepfar Countries — $3.3B (Partnership for Supply Chain Management Inc)
- - Ghsc Idiq - Malaria Task Order — $2.9B (Chemonics International, Inc.)
- NEW Malaria Task Order Under the Deliver IQC; 2 Year Base Base Contract, 1 Option Year — $1.1B (John Snow, Incorporated)